392 related articles for article (PubMed ID: 25444473)
1. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Miura JT; Gamblin TC
Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
[TBL] [Abstract][Full Text] [Related]
2. Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.
Xing M; Kooby DA; El-Rayes BF; Kokabi N; Camacho JC; Kim HS
J Surg Oncol; 2014 Aug; 110(2):182-96. PubMed ID: 24760444
[TBL] [Abstract][Full Text] [Related]
3. Chemoembolization of hepatic malignancy.
Gonsalves CF; Brown DB
Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
[TBL] [Abstract][Full Text] [Related]
4. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
Tsochatzis EA; Germani G; Burroughs AK
Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival after transarterial chemoembolization for hepatocellular carcinoma.
Iozzino M; Spaziani E; Picchio M; Saltarelli A; Di Filippo A; De Angelis F; Narilli F; Stagnitti F; Cianni R
Clin Ter; 2011; 162(2):129-32. PubMed ID: 21533319
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter treatment of hepatic metastases.
Pentecost MJ
AJR Am J Roentgenol; 1993 Jun; 160(6):1171-5. PubMed ID: 8388617
[TBL] [Abstract][Full Text] [Related]
7. Transarterial therapies for primary liver tumors.
Talenfeld AD; Sista AK; Madoff DC
Surg Oncol Clin N Am; 2014 Apr; 23(2):323-51. PubMed ID: 24560113
[TBL] [Abstract][Full Text] [Related]
8. Chemoembolization of hepatic malignancies.
Soulen MC
Oncology (Williston Park); 1994 Apr; 8(4):77-84; discussion 84, 89-90 passim. PubMed ID: 8003400
[TBL] [Abstract][Full Text] [Related]
9. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
Gannon CJ; Curley SA
Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
[TBL] [Abstract][Full Text] [Related]
10. [Chemoembolization and ethanol ablation of primary hepatic carcinoma and metastatic tumors].
Rudzki S; Jamroz A
Pol Merkur Lekarski; 2004 Jan; 16(91):78-81. PubMed ID: 15074029
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
14. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.
Shin JU; Kim KM; Shin SW; Min SY; Park SU; Sinn DH; Gwak GY; Choi MS; Lee JH; Paik SW; Yoo BC; Koh KC
Dig Liver Dis; 2014 Sep; 46(9):813-7. PubMed ID: 24881853
[TBL] [Abstract][Full Text] [Related]
15. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
Liu B; Huang JW; Li Y; Hu BS; He X; Zhao W; Zheng YB; Lu LG
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1103-8. PubMed ID: 25504506
[TBL] [Abstract][Full Text] [Related]
17. Re: Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.
Covey AM; Maluccio MA; Brody LA; Sofocleous CT; Getrajdman GI; Brown KT
J Vasc Interv Radiol; 2006 Jul; 17(7):1209; author reply 1209-10. PubMed ID: 16868176
[No Abstract] [Full Text] [Related]
18. Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma.
Lee EW; Khan S
Clin Mol Hepatol; 2017 Dec; 23(4):265-272. PubMed ID: 29113030
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for hepatocellular carcinoma.
Lau WY; Yu SC; Lai EC; Leung TW
J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
[No Abstract] [Full Text] [Related]
20. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies.
Lopez RR; Pan SH; Lois JF; McMonigle ME; Hoffman AL; Sher LS; Lugo D; Makowka L
Am Surg; 1997 Oct; 63(10):923-6. PubMed ID: 9322674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
